In what many experts are viewing as an unusual turn of events, an FDA advisory panel has voted to recommend that the agency order the inclusion of the most serious “black box” warning on all stimulant ADHD medications due to evidence of a potential risk of heart attacks, strokes, and sudden death. The drugs include amphetamines, such as Adderall, and methylphenidates, sold as Ritalin, Concerta, Methylin, and Metadate.
0 Responses to “FDA Advisory Committee Recommends ‘Black Box’ Warning for Ritalin, Adderall, Concerta, and Other ADHD Drugs for Potential Risk of Heart Attacks, Strokes, and Sudden Death”